Caedo Oncology AS

About Caedo Oncology AS

The startup develops monoclonal antibody treatments utilizing hybridoma technology to induce programmed cell death in cancer cells. This approach enhances treatment options for cancer patients by targeting specific pathways that lead to tumor cell elimination.

What does Caedo Oncology AS do?

The startup develops monoclonal antibody treatments utilizing hybridoma technology to induce programmed cell death in cancer cells. This approach enhances treatment options for cancer patients by targeting specific pathways that lead to tumor cell elimination.

Where is Caedo Oncology AS located?

Caedo Oncology AS is based in Oslo, Norway.

When was Caedo Oncology AS founded?

Caedo Oncology AS was founded in 2020.

Location
Oslo, Norway
Founded
2020
Employees
6 employees

Find Investable Startups and Competitors

Search thousands of startups using natural language

Start Searching

Caedo Oncology AS

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

The startup develops monoclonal antibody treatments utilizing hybridoma technology to induce programmed cell death in cancer cells. This approach enhances treatment options for cancer patients by targeting specific pathways that lead to tumor cell elimination.

caedooncology.com300+
cb
Crunchbase
Founded 2020 – Oslo, Norway

Funding

No funding information available.

Team (5+)

No team information available.
Want to add first party data to your startup here or get your entry removed? You can edit it yourself by logging in with your company domain.